• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Transl Psychiatry . Discovery of molecular signature of long-term psychiatric sequelae in COVID-19 through proteome profiling of dried blood spots

tetano

Editor, Senior Moderator
Transl Psychiatry


. 2025 Oct 10;15(1):389.
doi: 10.1038/s41398-025-03590-2. Discovery of molecular signature of long-term psychiatric sequelae in COVID-19 through proteome profiling of dried blood spots

Myungjae Baik[SUP] #[/SUP][SUP] 1 [/SUP], Jeonghun Yeom[SUP] #[/SUP][SUP] 2 [/SUP], Sang Min Lee[SUP] 1 [/SUP], Hwangkyo Jeong[SUP] 2 [/SUP], Ah Rah Lee[SUP] 1 [/SUP], Seungyoon Seo[SUP] 2 [/SUP], Sung Moon Choi[SUP] 3 [/SUP], Yeonwoo Jo[SUP] 2 [/SUP], Hye Yoon Park[SUP] 4 [/SUP], Eun Young Kim[SUP] 5 6 [/SUP], Jong-Woo Paik[SUP] 7 [/SUP]



Affiliations
Abstract

Neuropsychiatric sequelae represent a significant aspect of post-acute sequelae of SARS-CoV-2 (PASC, or long COVID), posing considerable public health challenges. This study identified molecular signatures associated with PASC in individuals with psychiatric morbidities via dried blood spot proteomic analysis. We evaluated 51 COVID-19 survivors ≥ 60 days post-infection, categorizing them into three groups: those with new-onset psychiatric disorders (n = 16, psychiatric PASC), those with persistent symptoms but no psychiatric disorders (n = 18, general PASC), and those symptomatically recovered (n = 17, recovered). Liquid chromatography-mass spectrometry analysis identified 1604 proteins. Differentially expressed proteins underwent Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses. Protein panels, including isoform 1 of fibronectin, sorbitol dehydrogenase, cytosolic acyl coenzyme A thioester hydrolase, and apolipoprotein A-II, differentiated psychiatric PASC from recovered individuals with an area under the curve (AUC) of 0.865 (95% CI: 0.658-1). Filamin A and vacuolar protein sorting-associated protein VTA1 homolog distinguished psychiatric PASC from general PASC at an AUC of 0.831 (95% CI: 0.6-1). Decision tree analysis revealed that alpha-synuclein, pyruvate kinase PKM, and sorbitol dehydrogenase effectively distinguished the three groups with 82% classification accuracy. These findings suggest that alterations in immune, glucose, and lipid metabolism pathways, along with neuroinflammation and neurodegeneration, contribute to the psychiatric PASC phenotype and highlight potential biomarkers for psychiatric disorders during the long-term COVID-19 clinical course.


 
Back
Top